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In humans, sulﬁte is generated endogenously by the metabolism of sulfur containing amino acids such as
methionine and cysteine. Sulﬁte is also formed from exposure to sulfur dioxide, one of the major en-
vironmental pollutants. Sulﬁte is used as an antioxidant and preservative in dried fruits, vegetables, and
beverages such as wine. Sulﬁte is also used as a stabilizer in many drugs. Sulﬁte toxicity has been as-
sociated with allergic reactions characterized by sulﬁte sensitivity, asthma, and anaphylactic shock.
Sulﬁte is also toxic to neurons and cardiovascular cells. Recent studies suggest that the cytotoxicity of
sulﬁte is mediated by free radicals; however, molecular mechanisms involved in sulﬁte toxicity are not
fully understood. Cytochrome c (cyt c) is known to participate in mitochondrial respiration and has
antioxidant and peroxidase activities. Studies were performed to understand the related mechanism of
oxidation of sulﬁte and radical generation by ferric cytochrome c (Fe3þcyt c) in the absence and presence
of H2O2. Electron paramagnetic resonance (EPR) spin trapping studies using 5,5-dimethyl-1-pyrroline-N-
oxide (DMPO) were performed with sulﬁte, Fe3þcyt c, and H2O2. An EPR spectrum corresponding to the
sulﬁte radical adducts of DMPO (DMPO-SO3-) was obtained. The amount of DMPO- −SO3 formed from the
oxidation of sulﬁte by the Fe3þcyt c increased with sulﬁte concentration. In addition, the amount of
DMPO- −SO3 formed by the peroxidase activity of Fe
3þcyt c also increased with sulﬁte and H2O2 con-
centration. From these results, we propose a mechanism in which the Fe3þcyt c and its peroxidase ac-
tivity oxidizes sulﬁte to sulﬁte radical. Our results suggest that Fe3þcyt c could have a novel role in the
deleterious effects of sulﬁte in biological systems due to increased production of sulﬁte radical. It also
shows that the increased production of sulﬁte radical may be responsible for neurotoxicity and some of
the injuries which occur to humans born with molybdenum cofactor and sulﬁte oxidase deﬁciencies.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In humans, sulﬁte is generated endogenously by the metabo-
lism of sulfur containing amino acids such as methionine and
cysteine [1]. Sulﬁte is also formed from exposure to sulfur dioxide,
one of the major environmental pollutants [2]. Sulﬁte is used as an
antioxidant and preservative in dried fruits, vegetables, pickled
onion, and beverages such as fruit juice, grape juice, beer, and
wine to prevent or reduce spoilage [2–4]. Sulﬁte is also used as a
stabilizer in many drugs and cosmetics [2,5,6]. For the majority of
people, exposure to sulﬁtes occurs during consumption of foods
and drinks that contain sulﬁte preservative [2]. Sulﬁte toxicity has
been associated with allergic reactions characterized by sulﬁte
sensitivity, asthma, chronic airway diseases, dermatitis,B.V. This is an open access article u
rive, University of Pittsburgh,anaphylactic shock, and early death [2,7,8]. The most frequently
reported physiological response for those sensitive to sulﬁte is
difﬁculty in breathing due to bronchoconstriction [2]. Steroid-de-
pendent asthmatics and children with chronic asthma are espe-
cially vulnerable to such toxicity [2]. Sulﬁte is also toxic to neurons
and cardiovascular system [9–14]. The level of sulﬁte in serumwas
found to be unregulated in several disease conditions, such as
pneumonia and end-stage renal failure [15,16]. Studies have sug-
gested that the cytotoxicity of sulﬁte is mediated by free radicals
[9,17,18]. There is no speciﬁc treatment for sulﬁte toxicity, and the
molecular mechanisms of the potentially toxic reactions of sulﬁte
are poorly understood.
In humans, sulﬁte is detoxiﬁed in the liver and lung to sulfate
by sulﬁte oxidase (SO), a molybdenum dependent mitochondrial
enzyme [19]. SO ensures that intracellular levels of the sulﬁte ion
remain at acceptably low levels. In cells, SO is localized in the in-
termembrane space of the mitochondria. Sulﬁte oxidation is the
ﬁnal step in the metabolism of sulfur derived from sulfurnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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or exogenous sulﬁte to sulfate, which is excreted in to the urine
[20]. In humans, SO deﬁciency is one of the most accepted causes
of sulﬁte hypersensitivity and toxicity [21]. A congenital deﬁciency
of SO can cause an excessive accumulation of sulﬁte and lead to
early death in infancy (usually between 2 and 6 years of age), or in
neonatal cases, neurological abnormalities, mental retardation,
intractable seizures, and ocular lens dislocation [8,20–22]. Mo-
lybdenum cofactor deﬁciency, which would compromise SO ac-
tivity, results in profound mental retardation, brain damage, mi-
crocephaly, and spasticity [23]. It has also been suggested that
hypoxic-ischemic encephalopathy is due to molybdenum cofactor
deﬁciency [21,24]. Importantly, in SO and molybdenum cofactor
deﬁciency cases, the level of sulﬁte is increased in plasma and
urine and also accumulates within the body [8,21,22,24–27]. De-
spite great advances in understanding the pathophysiology of SO
and molybdenum cofactor deﬁciencies [22,23], there are no
available therapies to reduce mortality or to improve quality of life
in survivors. Thus, a greater understanding of the mechanisms by
which excess sulﬁte leads to pathophysiological complications
could lead to the development of more effective therapies.
Under normal physiological conditions, SO catalyzes the oxi-
dation of sulﬁte to sulfate with cytochrome c (cyt c) as oxidizing
substrate as shown in Scheme 1 [28,29]. Mammalian cytochrome c
(cyt c) is a small, globular protein that exists in high concentra-
tions (0.5–5 mM) in the inner membrane of mitochondria [30,31].
At least 15% of cyt c is tightly bound to the inner membrane and
the remainder is loosely attached to the inner membrane and can
be readily mobilized [32]. Under physiological conditions, cyt c
mediates electron shuttling between cytochrome c reductase
(complex III) and cytochrome c oxidase (complex IV) during mi-
tochondrial respiration [32]. The loosely associate cyt c also
mediates superoxide removal, and prevents oxidative stress [32–
34], whereas the tightly bound cyt c accounts for the peroxidase
activity [35–39]. The peroxidase activity of cyt c increases under
conditions of oxidative and nitrosative stress [31,40,41]. Release of
cyt c from the inner mitochondrial membrane into the cytosol is a
pro-apoptotic factor [42,43]. Early in apoptosis, the redox function
of cyt c in the respiratory chain switches to a peroxidase function
[44,45]. The increased peroxidase activity of cyt c is implicated in
various neurodegenerative diseases, such as Parkinson's disease,
Alzheimer's disease, and amyotrophic lateral sclerosis (ALS) [46].
To gain a better understanding of the role of oxidized cytochrome
c (Fe3þcyt c) in oxidative sulﬁte toxicity, we have employed the
powerful, sensitive, and speciﬁc technique of electron para-
magnetic resonance (EPR) spin trapping technique to investigate
the oxidation of sulﬁte and generation of free radicals by the
Fe3þcyt c in the absence and presence of H2O2.2. Materials and methods
2.1. Materials
Oxidized cytochrome c (Fe3þcyt c, from horse heart), hydrogen
peroxide (H2O2), and sodium sulﬁte (Na2SO3) were purchasedScheme 1. Sulﬁte oxidase catalyzes the oxidation of sulﬁte to sulfate and reduces
oxidized cytochrome c.from Sigma. Diethylenetriaminepentaacetic acid (DTPA) and
2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) were obtained from
Aldrich. Puriﬁed 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) was
purchased from Dojindo laboratories, Kumamoto, Japan.
2.2. Electron Paramagnetic Resonance (EPR) measurements
EPR spectra were recorded using a quartz ﬂat cell at room
temperature with a Bruker ESP 300E spectrometer operating at
X-band with 100 kHz modulation frequency and a TM110 cavity.
The instrument settings were as follows: microwave frequency of
9.779 GHz, modulation amplitude of 0.5 G, microwave power of
20 mW, scan time of 30 s, time constant of 82 ms, and a single
scan. EPR spectral recording began two minutes after the addition
of H2O2. All the experiments were carried out in phosphate buffer
(50 mM and pH 7.4) containing 0.1 mM DTPA. Reactions were in-
itiated by the addition of H2O2. Quantitation of the observed free
radical signals was performed by computer simulation of the
spectra with comparison of the double integral of the observed
signal to that of a TEMPO standard (1 μM) measured under the
identical conditions [47].3. Results
3.1. EPR spin trapping studies of the oxidation of sulﬁte by Fe3þcyt c
It has been demonstrated that Fe3þcyt c can oxidize various
thiol compounds and superoxide radical [48–50]. To gain insight
into the molecular mechanisms involved in the process of oxida-
tion associated with sulﬁte toxicity, we studied the oxidation of
sulﬁte and free radical formation by Fe3þcyt c. EPR spin trapping is
a powerful technique to measure formation of free radical inter-
mediates. EPR spin trapping studies using the spin trap DMPO
were carried out to investigate the oxidation of sulﬁte by Fe3þcyt
c. EPR spectra were recorded from the reaction mixture containing
DMPO (0.1 M), Fe3þcyt c (0.1 mM), and sulﬁte (1 mM) in the
presence of DTPA (0.1 mM). A prominent EPR signal was seen,
corresponding to the sulﬁte radical adduct of DMPO (DMPO- −SO3),
as shown in Fig. 1A. From the EPR spectrum, the calculated iso-
tropic hyperﬁne coupling constants are aN¼14.57 G and aH
¼16.09 G, which are in agreement with previous reports [51]. In
the absence of Fe3þcyt c, a trace level of DMPO- −SO3 signal was
obtained, as shown in Fig. 1B. No EPR signal was obtained in the
absence of sulﬁte, as shown in Fig. 1C. These results show that
Fe3þcyt c oxidizes sulﬁte to form the sulﬁte radical.
The level of sulﬁte is increased under various pathological
conditions, including environmental exposure [2,3,25]. EPR spin
trapping studies were carried out with varying concentrations of
sulﬁte. The sulﬁte concentration dependence of sulﬁte radical
formation is shown in Fig. 2. The EPR signal intensity increases
with increasing sulﬁte concentration (Fig. 2).
3.2. EPR spin trapping studies of the oxidation of sulﬁte by Fe3þcyt c
in the presence of H2O2
In mitochondria, 1–2% of the oxygen consumed undergoes
partial reduction to form superoxide radical and hydrogen per-
oxide under physiological conditions [52]. It has been demon-
strated that Fe3þcyt c acts as a peroxidase and is involved in the
detoxiﬁcation of H2O2 [31,38]. During peroxidase activity, Fe3þcyt
c reacts with H2O2 to form the peroxidase Compound I-type in-
termediate, as shown in Scheme 2. The peroxidase activity of
Fe3þcyt c oxidizes various endogenous antioxidants/molecules
such as GSH, ascorbate, and NADH in the presence of H2O2, as
shown in Scheme 2 [31,49,53].
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Fig. 1. Room temperature EPR spectra of the sulﬁte radical adduct of DMPO,
DMPO- −SO3 . All the reactions were performed in 50 mM phosphate buffer (pH¼7.4)
containing 0.1 mM DTPA. Spectrum A: DMPO (0.1 M), Fe3þcyt c (0.1 mM), and
sulﬁte (1 mM). Spectrum B: DMPO (0.1 M) and sulﬁte (1 mM). Spectrum C: DMPO
(0.1 M) and Fe3þcyt c (0.1 mM). EPR instrument parameters used were as described
in the Materials and Methods section. EPR spectra are sum of 10 scans.
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Fig. 2. Top: room temperature EPR spectra of the sulﬁte radical adduct of DMPO,
DMPO- −SO3 . All the reactions were performed in 50 mM phosphate buffer (pH¼7.4)
containing 0.1 mM DTPA. Spectrum A: DMPO (0.1 M), Fe3þcyt c (0.1 mM), and
sulﬁte (0.25 mM). Spectrum B: DMPO (0.1 M), Fe3þcyt c (0.1 mM), and sulﬁte
(0.5 mM). Spectrum C: DMPO (0.1 M), Fe3þcyt c (0.1 mM), and sulﬁte (1 mM).
Spectrum D: DMPO (0.1 M), Fe3þcyt c (0.1 mM), and sulﬁte (2 mM). EPR instrument
parameters used were as described in the Materials and Methods section. EPR
spectra are sum of 10 scans. Bottom: Plot of the concentration of DMPO- −SO3 vs
Na2SO3. EPR spectra from the top panel were quantiﬁed by computer simulation
and comparison of the double integral of the observed signal with that of a TEMPO
standard (1 μM) measured under identical conditions. Data represent mean7SE
(n¼3).
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in sulﬁte toxicity, we studied the oxidation of sulﬁte and free ra-
dical generation by the Fe3þcyt c in the presence of H2O2. EPR spin
trapping studies using the spin trap DMPO were carried out to
investigate the oxidation of sulﬁte by Fe3þcyt c and H2O2. EPR
spectra were recorded from the reaction mixture containing
DMPO (0.1 M), Fe3þcyt c (0.1 mM), H2O2 (0.1 mM), and sulﬁte
(0.5 mM) in the presence of DTPA (0.1 mM). A prominent EPR
signal was seen corresponding to the sulﬁte radical adduct of
DMPO (DMPO- −SO3), as shown in Fig. 3A. In the absence of Fe
3þcyt
c, a weak signal of DMPO- −SO3 was obtained, as shown in Fig. 3B. A
trace level of the DMPO- −SO3 signal was obtained in the absence of
H2O2, as shown in Fig. 3C. No EPR signal was obtained in the ab-
sence of Fe3þcyt c and H2O2, as shown in Fig. 3D. These results
show that H2O2 alone oxidizes sulﬁte to the sulﬁte radical, but the
oxidation of sulﬁte to sulﬁte radical is greatly increased by the
combination of Fe3þcyt c and H2O2.
The level of sulﬁte is increased due to consumption of food and
drink containing sulﬁte preservatives and under pathological
conditions such as SO deﬁciency [2,21]. EPR spin trapping studies
were carried out with varying concentrations of sulﬁte and H2O2.
The sulﬁte concentration dependence of sulﬁte radical formation
is shown in Fig. 4. The EPR signal intensity increases with in-
creasing sulﬁte concentration (Fig. 4, Top). A plot of the initial rate
of formation of DMPO- −SO3 vs concentration of sulﬁte is linear up
to 0.25 mM and decreases at higher concentration of sulﬁte
(0.5 mM) as shown in Fig. 4, (Bottom).
The level of reactive oxygen species (ROS) is increased under
various pathological conditions such as ischemia/reperfusion and
diabetes [54–56]. The H2O2 concentration dependence of sulﬁte
radical formation is shown in Fig. 5. The EPR signal intensity in-
creases with increasing H2O2 concentration (Fig. 5, Top). A plot of
the initial rate of formation of DMPO- −SO3 vs concentration of H2O2
is linear up to 0.1 mM as shown in Fig. 5 (Bottom). These results
show that formation of sulﬁte radical increases with increasing
level of H2O2.4. Discussion
In this study, EPR spin trapping experiments were performed to
understand the molecular mechanisms involved in the sulﬁte
toxicity. Cyt c is found in high concentrations (0.5–5 mM) in the
inner membrane of mitochondria [30]. The results in Fig. 1 show
Scheme 2. Mechanism of activation of Fe3þcyt c to a peroxidase Compound I-type
intermediate by H2O2 and its oxidation of substrates.
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Fig. 3. Room temperature EPR spectra of the sulﬁte radical adduct of DMPO,
DMPO- −SO3 . All the reactions were performed in 50 mM phosphate buffer (pH¼7.4)
containing 0.1 mM DTPA. Spectrum A: DMPO (0.1 M), Fe3þcyt c (0.1 mM), sulﬁte
(0.5 mM), and H2O2 (0.1 mM). Spectrum B: DMPO (0.1 mM), sulﬁte (0.5 mM), and
H2O2 (0.1 mM). Spectrum C: DMPO (0.1 M), Fe3þcyt c (0.1 mM), and sulﬁte
(0.5 mM). Spectrum D: DMPO (0.1 M) and sulﬁte (0.5 mM). EPR instrument para-
meters used were as described in the Materials and Methods section. Each EPR
spectrum is a single scan.
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EPR spectra in Fig. 2 show that oxidation of sulﬁte to sulﬁte radical
by Fe3þcyt c increases with an increasing concentration of sulﬁte.
Studies have demonstrated that the sulﬁte radical further reacts
with oxygen to form peroxymonosulfate and sulfate radicals,Fig. 4. Top: room temperature EPR spectra of the sulﬁte radical adduct of DMPO,
DMPO- −SO3 . All the reactions were performed in 50 mM phosphate buffer (pH¼7.4)
containing 0.1 mM DTPA. Spectrum A: DMPO (0.1 M), Fe3þcyt c (0.1 mM), sulﬁte
(0.05 mM), and H2O2 (0.1 mM). Spectrum B: DMPO (0.1 M), Fe3þcyt c (0.1 mM),
sulﬁte (0.1 mM), and H2O2 (0.1 mM). Spectrum C: DMPO (0.1 M), Fe3þcyt c
(0.1 mM), sulﬁte (0.25 mM), and H2O2 (0.1 mM). Spectrum D: DMPO (0.1 M),
Fe3þcyt c (0.1 mM), sulﬁte (0.5 mM), and H2O2 (0.1 mM). EPR instrument para-
meters used were as described in the Materials and Methods section. Each EPR
spectrum is a single scan. Bottom: Plot of initial rate of formation of DMPO- −SO3
versus sulﬁte concentration. Rates were obtained from the initial slope of the for-
mation of DMPO- −SO3 . EPR spectra were quantiﬁed by computer simulation of the
spectra and comparison of the double integral of the observed signal with that of a
TEMPO standard (1 μM) measured under the identical conditions. Data represent
means7SE (n¼3).which are powerful oxidants, Scheme 3 [51]. However, the spin
trap DMPO (100 mM) competes with oxygen and scavenges sulﬁte
radical [51].
In cells, reactive oxygen species such as H2O2 are produced by
the mitochondria under physiological and pathophysiological
conditions [52]. In the mitochondrial intermembrane space, var-Na2SO3 [mM]
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Fig. 5. Top: room temperature EPR spectra of the sulﬁte radical adduct of DMPO,
DMPO- −SO3 . All the reactions were performed in 50 mM phosphate buffer (pH¼7.4)
containing 0.1 mM DTPA. Spectrum A: DMPO (0.1 M), Fe3þcyt c (0.1 mM), sulﬁte
(0.5 mM), and H2O2 (0.01 mM). Spectrum B: DMPO (0.1 M), Fe3þcyt c (0.1 mM),
sulﬁte (0.5 mM), and H2O2 (0.025 mM). Spectrum C: DMPO (0.1 M), Fe3þcyt c
(0.1 mM), sulﬁte (0.5 mM), and H2O2 (0.05 mM). Spectrum D: DMPO (0.1 M),
Fe3þcyt c (0.1 mM), sulﬁte (0.5 mM), and H2O2 (0.1 mM). EPR instrument para-
meters used were as described in the Materials and Methods section. Each EPR
spectrum is a single scan. Bottom. Plot of initial rate of formation of DMPO- −SO3 vs
H2O2 concentration. Rates were obtained from the initial slope of the formation of
DMPO- −SO3 . EPR spectra were quantiﬁed by computer simulation of the spectra and
comparison of the double integral of the observed signal with that of a TEMPO
standard (1 μM) measured under the identical conditions. Data represent mean-
s7SE (n¼3).
Scheme 3. Reactions of oxidation of sulﬁte radical to peroxymonosulfate and
sulfate radicals through chain propagation.
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Our EPR spin trapping experiments demonstrate the oxidation of
sulﬁte to sulﬁte radical by H2O2 (Fig. 3). The direct oxidation of
sulﬁte into sulﬁte radical by H2O2 occurs and can cause oxidative
damage to proteins, lipids, RNA, and DNA. Further, the oxidation of
sulﬁte to sulﬁte radical by Fe3þcyt c increases in the presence of
H2O2. The EPR results in Fig. 4 (Top) show that the oxidation of
sulﬁte by Fe3þcyt c in the presence of H2O2 increases with in-
creasing concentration of sulﬁte. A plot of the initial rate of for-
mation of DMPO- −SO3 as a function of sulﬁte concentration is linear
up to 0.5 mM (Fig. 4, Bottom). The EPR spectra in Fig. 5 (Top) show
that the oxidation of sulﬁte by Fe3þcyt c increasing with an in-
creasing concentration of H2O2. A plot of the initial rate of for-
mation of DMPO- −SO3 as function of H2O2 is linear (Fig. 5, Bottom),
indicating a ﬁrst-order dependence on H2O2. These EPR spin
trapping studies show that the increased production of ROS (H2O2)
increases the formation of the Compound I intermediate of
Fe3þcyt c which oxidizes sulﬁte to sulﬁte radical. These results
show that the increased production of H2O2 induces increased
production of sulﬁte radical.
Under normal physiological conditions, sulfur containing ami-
no acids such as methionine and cysteine are metabolized to
sulﬁte [59]. In addition, cysteine is also metabolized to H2S, which
functions as a cell signaling molecule in biology [59]. Under phy-
siological conditions, mitochondria also rapidly oxidize H2S to
thiosulfate and subsequently to sulﬁte and sulfate [59–61]. In
humans, SO is an essential protein residing in the mitochondrial
intermembrane space which catalyzes the essential oxidation/de-
gradation of endogenous or exogenous sulﬁte to sulfate, which is
excreted into the urine [20]. Simultaneously, the reduced SO re-
duces Fe3þcyt c to Fe2þcyt c, Scheme 1. In the mitochondrial
electron transport chain (ETC), Fe2þcyt c donates an electron to
cytochrome c oxidase (complex IV), which reduces molecular
oxygen to water [62]. Thus, SO and Fe3þcyt c play an important
role in protecting the mitochondria/cells/tissues from sulﬁte
toxicity.
In wine, sulﬁte is used as a preservative and can reach the
concentration of 6 mM [3,4,63]. In asthmatic patients, asthma
symptoms are sometimes worsened after alcohol consumption
[64]. A cohort study has reported that sulﬁte in wine triggers
asthmatic reactions [65]. Very little is known about the mechan-
isms involved in these reactions. EPR spin trapping studies show
that oxidation of sulﬁte to the sulﬁte radical by Fe3þcyt c in the
absence/presence of H2O2 increases with increasing concentration
of sulﬁte. This shows that this reaction may play an important role
in the wine-induced asthmatic responses. This also suggests that
Fe3þcyt c could be involved in oxidative damage and tissue injury
in sulﬁte-exacerbated allergic reactions.
Sulfur dioxide is one of the major air pollutants near large cities
[66]. In the nasal passage and lung, sulfur dioxide is hydrated ra-
pidly into bisulﬁte and sulﬁte [67]. In aqueous medium, bisulﬁte
and sulﬁte are in equilibrium [67]. At physiological pH, sulﬁte
predominates over bisulﬁte [67]. Exposure to sulfur dioxide in-
duces accumulation of neutrophils into the airways [68]. Sulﬁte
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neutrophils [69]. It has been demonstrated that sulﬁte is oxidized
to the sulﬁte radical by guinea pig lung microsomes [67]. In hu-
mans, SO is expressed in the alveoli and tissues of lung and liver
[70,71]. However, the expression and activity of SO is very low in
human lung tissue (135-fold lower than liver) [70]. It has been
suggested that various peroxidase enzymes are involved in the
oxidation of sulﬁte to sulﬁte radical in sulﬁte toxicity [67]. Very
recently, it has been proposed that the peroxidase activity of
Fe3þcyt c is involved in the oxidation of phospholipids in the lungs
exposed to air pollutants [72]. Highly reactive sulﬁte radical can
oxidize lipids. Our EPR spin trapping experiments show that oxi-
dation of sulﬁte by Fe3þcyt c in the presence of H2O2 increases the
generation of sulﬁte radical. This study shows that Fe3þcyt c may
play a major role in sulﬁte toxicity in lungs exposed to environ-
mental air pollutants such as sulfur dioxide.
Sulﬁte is one of the few sulfating agents approved by the Food
and Drug Administration as a food preservative and antioxidant to
prevent or reduce spoilage [3]. It is also used as an ingredient of
many medications, such as antibiotics, analgesics, and anesthetics
[2,5,6]. It has been suggested that the presence of sulﬁte in dex-
amethasone preparations has increased its neurotoxicity of the
preparation [73]. However, the molecular mechanisms involved in
this neurotoxicity are not known. The increased peroxidase ac-
tivity of Fe3þcyt c is implicated in various neurodegenerative
diseases, such as Parkinson's disease, Alzheimer's disease, and ALS
[46]. Exposure of rat neuronal cells to sulﬁte increases cell death
by apoptosis [18]. The release of cyt c is an early step in apoptosis
[42,43]. Moreover, the peroxidase activity of cyt c increases during
apoptosis [74,75]. Exposure to sulﬁte results in DNA fragmenta-
tion, characteristic of apoptosis [18]. It has been shown that sulﬁte
radical can damage DNA [76,77]. However, the source of the for-
mation of sulﬁte radical in neuronal cell death is not known. Based
on our EPR spin trapping results, we propose that increased pro-
duction of sulﬁte radical due to the oxidation of sulﬁte by Fe3þcyt
c may be responsible for DNA fragmentation, apoptosis, increased
neurotoxicity, and neuronal cell death.
In humans, SO is expressed in liver, kidney, skeletal muscle,
heart, placenta, and brain [78]. The loss of SO is fatal in infancy or
early childhood [21]. In SO-deﬁcient and functional loss of SO
patients, the main clinical symptoms are severe progressive neu-
rologic damage, attenuated brain growth, mental retardation and
alterations in muscle tone [79,80]. SO deﬁciency is also one of the
most accepted causes of sulﬁte hypersensitivity and toxicity [21].
In cases of SO deﬁciency and molybdenum cofactor deﬁciency, the
levels of sulﬁte and sulfo derivatives of amino acids, proteins, and
various compounds are increased in urine [21,24]. SO deﬁciency
also results in the accumulation of sulﬁte in various tissues,
especially in the brain [81]. However, the molecular mechanisms
involved are not fully understood. In clinical studies of SO and
molybdenum cofactor deﬁciencies, it was proposed that neuronal
toxicity was due to decreased ATP or energy deﬁcit/failure [82,83].
It has also been suggested that excess sulﬁte might damage mi-
tochondrial function via disruption of membrane integrity [9,84].
In rat brain, mitochondrial sulﬁte induced a decrease in ATP
synthesis and disturbance of mitochondrial energy homeostasis
[9,81]. In neurons and human fetal liver cells, it has also been
shown that ATP is depleted due to sulﬁte toxicity [9]. Similar ob-
servations were made in rat kidney mitochondria and other non-
neuronal cells [85]. In addition, it has been shown that sulﬁte in-
hibits mitochondrial glutamate dehydrogenase activity [9]. How-
ever, the molecular mechanisms involved in the inactivation of
mitochondria and its enzymes are still unclear.
Mitochondrial dysfunction contributes to the pathophysiology of
neurologic disorders and neurodegenerative diseases [86]. Accumula-
tion of damaged mitochondria is associated with neurodegenerativediseases [87]. The disorders of mitochondrial oxidative phosphoryla-
tion are associated with neurodegenerative diseases [88]. Mitochon-
drial precursor proteins (99%) are synthesized in cytosol [89]. Pre-
cursor proteins targeted to mitochondria are imported in to the mi-
tochondrial matrix by the protein transport machinery localized in the
outer and inner membrane of mitochondria [89,90]. Similarly, RNAs
and heme are imported into mitochondria by the PNPASE protein and
translocator protein (TSPO) respectively, residing in the mitochondrial
intermembrane space [91–93].
During mitochondrial ﬁssion, various nuclear encoded proteins
and transcription factors are transported into the preexisting mi-
tochondria and imported before ﬁssion and subsequent in-
corporation into the mitochondrial network [86,94]. Abnormalities
in mitochondrial ﬁssion have been identiﬁed in several neurode-
generative diseases [86]. It has been demonstrated that sulﬁte
toxicity is due to the increased production of ROS in the mi-
tochondria and inactivation of mitochondrial proteins [9]. Studies
have also shown that sulﬁte radical is capable of damaging DNA/
RNA, lipids, and proteins [51,76,77, 95–97]. The increased pro-
duction of oxidants can damage the mitochondrial proteins, lipids,
DNA/RNA and this is implicated in several neurological diseases
[86,91,98].
Our EPR spin trapping studies show that H2O2 can directly
oxidize sulﬁte to the sulﬁte radical, and that Fe3þcyt c, a mi-
tochondrial protein, oxidizes sulﬁte to the sulﬁte radical in the
absence or presence of H2O2. The increased production of sulﬁte
radical in the mitochondrial intermembrane space can damage the
proteins, lipids, DNA/RNA and proteins involved in various trans-
port machinery/processes. Moreover, the increased production of
oxidants increases the oxidation of mitochondrial innermembrane
cardiolipin [31,99]. Oxidized cardiolipin translocates to the mi-
tochondrial outer membrane and enhances apoptosis [86]. In rats,
it has been shown that sulﬁte disrupts brain mitochondrial energy
homeostasis, increases swelling, and induces mitochondrial per-
meability transition (MPT) pore opening [81]. MPT pore opening
inhibits the ETC complex I activity, releases cyt c, and increases
apoptosis [81,100]. In the arterial system, sympathetic neurons
dictate the distribution of blood ﬂow and oxygen transport, de-
pendent on need [101]. Defective sympathetic neurons lead to
cerebral hypoperfusion [101]. Hence, the increased production of
highly reactive sulﬁte/sulfate radical by the Fe3þcyt c and H2O2
can alter the physiological functions and dynamics of mitochon-
dria and increase apoptosis and necrosis, which results in in-
creased neurotoxicity, hypoperfusion, and neuronal cell death.
Therefore, mitochondria are important targets for neuroprotective
interventions. Mitochondria have been targeted by many experi-
mental neuroprotective interventions [86]. Our EPR results suggest
that radical metabolism may be central to the pathogenesis of SO
and molybdenum cofactor deﬁciencies.
Based on our studies and reported literature, we propose that
Fe3þcyt c in the absence and presence of H2O2 is involved in the
oxidation of sulﬁte to the sulﬁte radical and facilitation of electron
ﬂow in the ETC as depicted in Fig. 6.
In conclusion, under physiological conditions, SO and Fe3þcyt c
play a protective role in detoxifying sulﬁte in the mitochondrial
intermembrane space. However, with elevated levels of sulﬁte and
pathophysiological conditions accompanied by oxidative stress,
the oxidation of sulﬁte by Fe3þcyt c and/or H2O2 causes potentially
toxic reactions between the sulﬁte radical intermediate and bio-
logically important molecules such as proteins, lipids, and DNA.
The highly reactive sulﬁte/sulfate radical can damage the transport
machinery involved in the transport of proteins, RNAs, heme, and
various other biomolecules in to mitochondria and disrupts mi-
tochondrial energy homeostasis. The oxidation of sulﬁte into sul-
ﬁte radical by Fe3þcyt c and/or H2O2 in mitochondria may be re-
sponsible for some of the damage which occurs in humans born
Fig. 6. Proposed model of cytochrome c-mediated oxidation of sulﬁte to sulﬁte radical and alternative electron transfer pathway in mitochondria. The oxidation of sulﬁte by
sulﬁte oxidase and cytochrome c are two and one electron processes respectively.
M. Velayutham et al. / Biochemistry and Biophysics Reports 5 (2016) 96–104102with SO and/or molybdenum cofactor deﬁciencies. Targeted
clearance and replacement of damaged organelles has been
identiﬁed as a neuroprotective strategy against acute neural injury
[102]. Hence, sulﬁte-mediated mitochondrial injury may be of key
importance in sulﬁte mediated neurological and systemic
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